MILPITAS, Calif.--(BUSINESS WIRE)--Spectra Laboratories, Inc., a leading provider of renal-specific testing services, announced today that the American Association for Laboratory Accreditation (A2LA) awarded its Milpitas, California facility an accreditation in accordance with stringent international requirements of ISO 15189:2007 Medical Laboratories – Particular requirements for quality and competence. This is the second ISO 15189 accreditation from A2LA to be earned by a medical testing laboratory in the United States. The first ISO 15189 accreditation from A2LA was awarded to Spectra’s partner laboratory in Rockleigh, New Jersey on May 20, 2010. Spectra Laboratories is a unit of Fresenius Medical Care North America (NYSE:FMS).
